Costliest New Drugs Escape Patient, Insurer Revolt
550204
CHICAGO/NEW YORK  - When it comes to the price tag  for the newest biotechology drugs for cancer and other  hard-to-treat diseases, the sky is likely to remain the limit,  insurers, drugmakers and industry watchers say.
433075
When pharmaceutical giant Merck &amp; Co. abruptly pulled its arthritis pain medication Vioxx from the marketplace on Sept. 30, more than 2 million patients were taking the drug.
734267
By Thomas Ginsberg, The Philadelphia Inquirer  Jan. 31--Here is something you may not hear every day: The drug giant Wyeth said yesterday that it was "surprised" to hear that it is about to face generic competition on its $216 million heart drug Inderal LA.
575599
Patients losing their sight say they are being denied access to a drug which could stop them from going blind.
727152
New developments are brewing at the pharmaceutical.
599880
Federal number crunchers said yesterday that the new Medicare drug benefit appears to be slowing the growth in national spending on prescription medicines because the drug plans are negotiating lower prices with drug companies.
505776
A big reason for the high cost of health insurance is the explosion of expensive, medically questionable care.
298112
An Oregon man stopped taking the painkiller Vioxx when it was pulled from the market, switching to Bextra. Then questions about Bextra -- and four other drugs -- sent him back to his doctor with a new set of worries.
478185
With complicated and costly "biologics"  increasingly seen as the wave of the pharmaceutical future, health care experts warn that they will drive the nation's fast-growing bill for drugs far higher.
184248
Averse to risk? Check out these nontraditional drug companies.
665303
A patient-compliance study shows that its only drug offers no better solution.
100064
Research and development costs drag down the drug developer's bottom line.
256160
A major component in the skyrocketing cost of health care in America is prescription drug costs. Whatever final solution the country comes to about how to handle health care, one thing is clear, pharmaceutical
227456
Many chronically ill patients never tell their doctor or nurse they've had to cut back on prescription drugs because they are too expensive, and many physicians never ask if the drugs are unaffordable, a study said on Monday.
724288
Two-thirds of chronically ill patients failed to tell their doctors they would have to skimp on their medicines because of cost, according to a new study published yesterday.
559893
New Yorkâs attorney general is looking into if insurers forced patients to overpay for out-of-network doctors.
600288
Bristol-Myers Squibb's new drug doesn't work better, but it's easier to take.